- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Potential New Approaches for Prostate Cancer Management in Resource-Limited Countries in Africa.
March 1, 2023
Standardized prostate cancer incidence and mortality rates following initial non-malignant biopsy result.
March 1, 2023
Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap.
February 28, 2023
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer.
February 28, 2023
Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.
February 28, 2023
Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review.
February 28, 2023
Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine.
February 27, 2023
Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review.
February 27, 2023
A Personalised Clinical Dynamic Prediction Model to Characterise Prognosis for Patients with Localised Prostate Cancer: analysis of the CHHiP Phase III Trial.
February 27, 2023
UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer.
February 27, 2023
BMX controls 3βHSD1 and sex steroid biosynthesis in cancer.
February 27, 2023
Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer.
February 27, 2023
Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.
February 27, 2023